Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

Ischaemic optic neuropathy (ION) is a rare but vision-threatening complication recently linked to GLP-1 receptor agonists, particularly semaglutide. Using over 30 million reports from the FDA Adverse ...

As an increasing number of patients come forward with claims that their vision has been permanently impacted by weight loss jabs, eye experts have issued a vital statistical warni ...

An increased risk for ischemic optic neuropathy may be associated with formulation- and dose-dependent GLP-1 receptor agonist use.

Semaglutide was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 diabetes. The risk was more modest than previously reported. Using the specific ...

Veterans with type 2 diabetes had a higher risk for nonarteritic anterior ischemic optic neuropathy (NAION) after starting semaglutide versus SGLT2 inhibitors. Absolute risk of the potentially ...

Share on Pinterest Researchers believe that high doses of semaglutide may reduce blood flow to the optic nerve, which could lead to eye stroke. Maria Korneeva/Getty Images A new study has found that ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

Worsening of vision occurred within a few weeks after onset of symptoms in most eyes with nonarteritic anterior ischemic optic neuropathy (NAION) that progressed. Only a past episode in the other eye, ...

Please provide your email address to receive an email when new articles are posted on . “Population-based detailed information about the prevalences of all three types of optic nerve damage and their ...